Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 113,367

Sort by:

2019 Future of Chronic Urticaria/Hives R&D Pipeline Drugs and Companies- Analysis of Global Chronic Urticaria Or Hives Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... of the Chronic Urticaria Or Hives pipeline companies from advancing their products into Phase 3 or Phase 4. Chronic Urticaria Or Hives Report Description The H1 2019 pipeline review report on Chronic Urticaria Or Hives pipeline is a comprehensive ...

January 2019 65 pages

2019 Future of Contact Dermatitis R&D Pipeline Drugs and Companies- Analysis of Global Contact Dermatitis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Contact Dermatitis Report Description The H1 2019 pipeline review report on Contact Dermatitis pipeline is a comprehensive study on ... and actionable insights. Scope of Contact Dermatitis pipeline report includes An overview of Contact Dermatitis disease including symptoms, causes, ...

January 2019 40 pages

2019 Future of Coronary Artery Disease (CAD)/Ischemic Heart Disease R&D Pipeline Drugs and Companies- Analysis of Global Coronary Artery Disease (CAD) (Ischemic Heart Disease) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... 3 or Phase 4. Coronary Artery Disease (CAD) (Ischemic Heart Disease) Report Description The H1 2019 pipeline review report on Coronary Artery Disease (CAD) ( ... originating companies, license providers and universities participating in the Coronary Artery Disease (CAD) (Ischemic Heart Disease) product pipeline ...

January 2019 120 pages

2019 Future of Critical Limb Ischemia R&D Pipeline Drugs and Companies- Analysis of Global Critical Limb Ischemia Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Critical Limb Ischemia Report Description The H1 2019 pipeline review report on Critical Limb Ischemia pipeline is a comprehensive study ... presents detailed analysis on all active Critical Limb Ischemia pipeline compounds. The Critical Limb Ischemia pipeline guide presents information ...

January 2019 100 pages

2019 Future of Deep Vein Thrombosis (DVT) R&D Pipeline Drugs and Companies- Analysis of Global Deep Vein Thrombosis (DVT) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... their products into Phase 3 or Phase 4. Deep Vein Thrombosis (DVT) Report Description The H1 2019 pipeline review report on Deep Vein Thrombosis (DVT) pipeline is a comprehensive study ...

January 2019 40 pages

2019 Future of Dilated Cardiomyopathy R&D Pipeline Drugs and Companies- Analysis of Global Dilated Cardiomyopathy Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Dilated Cardiomyopathy Report Description The H1 2019 pipeline review report on Dilated Cardiomyopathy pipeline is a comprehensive study ... insights. Scope of Dilated Cardiomyopathy pipeline report includes An overview of Dilated Cardiomyopathy disease including symptoms, causes ...

January 2019 60 pages

2019 Future of Epidermolysis Bullosa R&D Pipeline Drugs and Companies- Analysis of Global Epidermolysis Bullosa Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Epidermolysis Bullosa Report Description The H1 2019 pipeline review report on Epidermolysis Bullosa pipeline is a comprehensive study on ... actionable insights. Scope of Epidermolysis Bullosa pipeline report includes An overview of Epidermolysis Bullosa disease including symptoms, causes ...

January 2019 90 pages

2019 Future of Graves Diseases R&D Pipeline Drugs and Companies- Analysis of Global Graves Diseases Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Graves Diseases Report Description The H1 2019 pipeline review report on Graves Diseases pipeline is a comprehensive study on ... and actionable insights. Scope of Graves Diseases pipeline report includes An overview of Graves Diseases disease including symptoms, causes, diagnosis ...

January 2019 40 pages

2019 Future of Hidradenitis Suppurativa R&D Pipeline Drugs and Companies- Analysis of Global Hidradenitis Suppurativa Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Hidradenitis Suppurativa Report Description The H1 2019 pipeline review report on Hidradenitis Suppurativa pipeline is a comprehensive study on the candidates in development ...

January 2019 85 pages

2019 Future of Hypertrophic Cardiomyopathy R&D Pipeline Drugs and Companies- Analysis of Global Hypertrophic Cardiomyopathy Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Hypertrophic Cardiomyopathy Report Description The H1 2019 pipeline review report on Hypertrophic Cardiomyopathy pipeline is a comprehensive study on the candidates in development ...

January 2019 60 pages

2019 Future of Hypoparathyroidism R&D Pipeline Drugs and Companies- Analysis of Global Hypoparathyroidism Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Hypoparathyroidism Report Description The H1 2019 pipeline review report on Hypoparathyroidism pipeline is a comprehensive study on the candidates in development ...

January 2019 40 pages

2019 Future of Hypotension R&D Pipeline Drugs and Companies- Analysis of Global Hypotension Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Hypotension Report Description The H1 2019 pipeline review report on Hypotension pipeline is a comprehensive study on the candidates in development ...

January 2019 50 pages

2019 Future of Hypothyroidism R&D Pipeline Drugs and Companies- Analysis of Global Hypothyroidism Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Hypothyroidism Report Description The H1 2019 pipeline review report on Hypothyroidism pipeline is a comprehensive study on the candidates in development ...

January 2019 35 pages

2019 Future of Intermittent Claudication R&D Pipeline Drugs and Companies- Analysis of Global Intermittent Claudication Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Intermittent Claudication Report Description The H1 2019 pipeline review report on Intermittent Claudication pipeline is a comprehensive study on the candidates in development ...

January 2019 55 pages

2019 Future of Ischemia Reperfusion Injury R&D Pipeline Drugs and Companies- Analysis of Global Ischemia Reperfusion Injury Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... Phase 3 or Phase 4. Ischemia Reperfusion Injury Report Description The H1 2019 pipeline review report on Ischemia Reperfusion Injury pipeline is a comprehensive ... detailed analysis on all active Ischemia Reperfusion Injury pipeline compounds. The Ischemia Reperfusion Injury pipeline guide presents information ...

January 2019 100 pages

2019 Future of Keloids R&D Pipeline Drugs and Companies- Analysis of Global Keloids Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... of the Keloids pipeline companies from advancing their products into Phase 3 or Phase 4. Keloids Report Description The H1 2019 pipeline review ... report on Keloids pipeline is a comprehensive study on the candidates ...

January 2019 40 pages

2019 Future of Left Ventricular Dysfunction R&D Pipeline Drugs and Companies- Analysis of Global Left Ventricular Dysfunction Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... Phase 3 or Phase 4. Left Ventricular Dysfunction Report Description The H1 2019 pipeline review report on Left Ventricular Dysfunction pipeline is a comprehensive ... detailed analysis on all active Left Ventricular Dysfunction pipeline compounds. The Left Ventricular Dysfunction pipeline guide presents ...

January 2019 50 pages

2019 Future of Meniere Disease R&D Pipeline Drugs and Companies- Analysis of Global Meniere Disease Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Meniere Disease Report Description The H1 2019 pipeline review report on Meniere Disease pipeline is a comprehensive study on ... and actionable insights. Scope of Meniere Disease pipeline report includes An overview of Meniere Disease disease including symptoms, causes, diagnosis ...

January 2019 45 pages

2019 Future of Microscopic Polyangiitis (MPA) R&D Pipeline Drugs and Companies- Analysis of Global Microscopic Polyangiitis (MPA) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Microscopic Polyangiitis (MPA) Report Description The H1 2019 pipeline review report on Microscopic Polyangiitis (MPA) pipeline is a ... detailed analysis on all active Microscopic Polyangiitis (MPA) pipeline compounds. The Microscopic Polyangiitis (MPA) pipeline guide presents ...

January 2019 45 pages

2019 Future of Myocardial Fibrosis R&D Pipeline Drugs and Companies- Analysis of Global Myocardial Fibrosis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Myocardial Fibrosis Report Description The H1 2019 pipeline review report on Myocardial Fibrosis pipeline is a comprehensive study on ... and actionable insights. Scope of Myocardial Fibrosis pipeline report includes An overview of Myocardial Fibrosis disease including symptoms, causes, ...

January 2019 75 pages

2019 Future of Myocardial Ischemia R&D Pipeline Drugs and Companies- Analysis of Global Myocardial Ischemia Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Myocardial Ischemia Report Description The H1 2019 pipeline review report on Myocardial Ischemia pipeline is a comprehensive study on ... and actionable insights. Scope of Myocardial Ischemia pipeline report includes An overview of Myocardial Ischemia disease including symptoms, causes, ...

January 2019 60 pages

2019 Future of Myocarditis R&D Pipeline Drugs and Companies- Analysis of Global Myocarditis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Myocarditis Report Description The H1 2019 pipeline review report on Myocarditis pipeline is a comprehensive study on the candidates in development ...

January 2019 40 pages

2019 Future of Nasal Polyps R&D Pipeline Drugs and Companies- Analysis of Global Nasal Polyps Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Nasal Polyps Report Description The H1 2019 pipeline review report on Nasal Polyps pipeline is a comprehensive study on the ... clear and actionable insights. Scope of Nasal Polyps pipeline report includes An overview of Nasal Polyps disease including symptoms, causes, diagnosis ...

January 2019 60 pages

2019 Future of Nasopharyngitis (Common Cold) R&D Pipeline Drugs and Companies- Analysis of Global Nasopharyngitis (Common Cold) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Nasopharyngitis (Common Cold) Report Description The H1 2019 pipeline review report on Nasopharyngitis (Common Cold) pipeline is a comprehensive ... detailed analysis on all active Nasopharyngitis (Common Cold) pipeline compounds. The Nasopharyngitis (Common Cold) pipeline guide presents ...

January 2019 40 pages

2019 Future of Otitis Media R&D Pipeline Drugs and Companies- Analysis of Global Otitis Media Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Otitis Media Report Description The H1 2019 pipeline review report on Otitis Media pipeline is a comprehensive study on the ... clear and actionable insights. Scope of Otitis Media pipeline report includes An overview of Otitis Media disease including symptoms, causes, diagnosis ...

January 2019 60 pages

2019 Future of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) R&D Pipeline Drugs and Companies- Analysis of Global Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... Phase 3 or Phase 4. Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Report Description The H1 2019 pipeline review report on Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD ...

January 2019 120 pages

2019 Future of Pressure Ulcers R&D Pipeline Drugs and Companies- Analysis of Global Pressure Ulcers Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Pressure Ulcers Report Description The H1 2019 pipeline review report on Pressure Ulcers pipeline is a comprehensive study on the ... and actionable insights. Scope of Pressure Ulcers pipeline report includes An overview of Pressure Ulcers disease including symptoms, causes, ...

January 2019 35 pages

2019 Future of Pruritus R&D Pipeline Drugs and Companies- Analysis of Global Pruritus Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Pruritus Report Description The H1 2019 pipeline review report on Pruritus pipeline is a comprehensive study on the candidates in development ...

January 2019 85 pages

2019 Future of Pulmonary Embolism R&D Pipeline Drugs and Companies- Analysis of Global Pulmonary Embolism Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Pulmonary Embolism Report Description The H1 2019 pipeline review report on Pulmonary Embolism pipeline is a comprehensive study on ... and actionable insights. Scope of Pulmonary Embolism pipeline report includes An overview of Pulmonary Embolism disease including symptoms, causes, ...

January 2019 40 pages

2019 Future of Raynauds Disease R&D Pipeline Drugs and Companies- Analysis of Global Raynauds Disease Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Raynauds Disease Report Description The H1 2019 pipeline review report on Raynauds Disease pipeline is a comprehensive study on ... and actionable insights. Scope of Raynauds Disease pipeline report includes An overview of Raynauds Disease disease including symptoms, causes, diagnosis ...

January 2019 40 pages

2019 Future of Restenosis R&D Pipeline Drugs and Companies- Analysis of Global Restenosis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Restenosis Report Description The H1 2019 pipeline review report on Restenosis pipeline is a comprehensive study on the candidates in development ...

January 2019 45 pages

2019 Future of Rosacea R&D Pipeline Drugs and Companies- Analysis of Global Rosacea Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... of the Rosacea pipeline companies from advancing their products into Phase 3 or Phase 4. Rosacea Report Description The H1 2019 pipeline review ... report on Rosacea pipeline is a comprehensive study on the candidates ...

January 2019 60 pages

2019 Future of Scar R&D Pipeline Drugs and Companies- Analysis of Global Scar Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... of the Scar pipeline companies from advancing their products into Phase 3 or Phase 4. Scar Report Description The H1 2019 pipeline review ... report on Scar pipeline is a comprehensive study on the candidates ...

January 2019 75 pages

2019 Future of Secondary Hyperparathyroidism R&D Pipeline Drugs and Companies- Analysis of Global Secondary Hyperparathyroidism Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Secondary Hyperparathyroidism Report Description The H1 2019 pipeline review report on Secondary Hyperparathyroidism pipeline is a comprehensive study on the candidates in development ...

January 2019 40 pages

2019 Future of Sinusitis R&D Pipeline Drugs and Companies- Analysis of Global Sinusitis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Sinusitis Report Description The H1 2019 pipeline review report on Sinusitis pipeline is a comprehensive study on the candidates in development ...

January 2019 75 pages

2019 Future of Thromboembolism R&D Pipeline Drugs and Companies- Analysis of Global Thromboembolism Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Thromboembolism Report Description The H1 2019 pipeline review report on Thromboembolism pipeline is a comprehensive study on the candidates in development ...

January 2019 75 pages

2019 Future of Tinnitus R&D Pipeline Drugs and Companies- Analysis of Global Tinnitus Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Tinnitus Report Description The H1 2019 pipeline review report on Tinnitus pipeline is a comprehensive study on the candidates in development ...

January 2019 50 pages

2019 Future of Vaso Occlusive Crisis Associated With Sickle Cell Disease R&D Pipeline Drugs and Companies- Analysis of Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... With Sickle Cell Disease Report Description The H1 2019 pipeline review report on Vaso-Occlusive Crisis Associated With Sickle Cell Disease pipeline is ... originating companies, license providers and universities participating in the Vaso-Occlusive Crisis Associated With Sickle Cell Disease product pipeline are ...

January 2019 75 pages

2019 Future of Venous Leg Ulcers (Crural ulcer) R&D Pipeline Drugs and Companies- Analysis of Global Venous Leg Ulcers (Crural ulcer) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Venous Leg Ulcers (Crural ulcer) Report Description The H1 2019 pipeline review report on Venous Leg Ulcers (Crural ulcer) pipeline is a comprehensive ...

January 2019 60 pages

2019 Future of Ventricular Tachycardia R&D Pipeline Drugs and Companies- Analysis of Global Ventricular Tachycardia Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Ventricular Tachycardia Report Description The H1 2019 pipeline review report on Ventricular Tachycardia pipeline is a comprehensive study ... insights. Scope of Ventricular Tachycardia pipeline report includes An overview of Ventricular Tachycardia disease including symptoms, causes ...

January 2019 50 pages

2019 Future of Vitiligo R&D Pipeline Drugs and Companies- Analysis of Global Vitiligo Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Vitiligo Report Description The H1 2019 pipeline review report on Vitiligo pipeline is a comprehensive study on the candidates in development ...

January 2019 65 pages

Global Herbal Medicines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... are 15 Chapters to deeply display the global Herbal Medicines market. Chapter 1, to describe Herbal Medicines Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the ...

January 2019 135 pages

Global Stem Cell Therapy Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

US$ 3,480.00

... ; this report analyzes the top players in global market, and splits the Stem Cell Therapy market by product type and applications/end industries. ... area; there will be more investments to enter the field. The global Stem Cell Therapy market is valued at xx million USD in 2017 and is expected to reach xx ...

January 2019 139 pages

Global Gastrointestinal Therapeutics and Diagnostics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... There are 15 Chapters to deeply display the global Gastrointestinal Therapeutics and Diagnostics market. Chapter 1, to describe Gastrointestinal Therapeutics and Diagnostics Introduction, product scope, market overview, market opportunities ...

January 2019 117 pages

Global Hemophilia Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... are 15 Chapters to deeply display the global Hemophilia Treatment market. Chapter 1, to describe Hemophilia Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the ...

January 2019 118 pages

Global Pneumonia Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... REPORT: This report focuses on the Pneumonia Therapeutics in global market, especially in North America, Europe and ... the global Pneumonia Therapeutics market. Chapter 1, to describe Pneumonia Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force ...

January 2019 124 pages

Global Small Cell Lung Cancer Therapeutics Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

US$ 3,480.00

... top players in global market, and splits the Small Cell Lung Cancer Therapeutics market by product type and applications/end industries. The global Small Cell Lung Cancer Therapeutics market is valued ...

January 2019 137 pages

Global Smart Healthcare Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

US$ 3,480.00

... ; this report analyzes the top players in global market, and splits the Smart Healthcare market by product type and applications/end industries. ... will contribute the most to the growth of this market by the end of 2023. The global Smart Healthcare market is valued at xx million USD in 2017 and is expected ...

January 2019 117 pages

Global Hormone Refractory Prostate Cancer (HRPCA) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... REPORT: This report focuses on the Hormone Refractory Prostate Cancer (HRPCA) in global market, especially in North America, Europe ... Chapters to deeply display the global Hormone Refractory Prostate Cancer (HRPCA) market. Chapter 1, to describe Hormone Refractory Prostate Cancer (HRPCA) Introduction, product ...

January 2019 102 pages

Global Morphine Sulfate Market Research Report 2012-2024

US$ 1,800.00

... global Morphine Sulfate market will reach Volume Million USD in 2017 with CAGR xx% 2019-2023. The objective of report is to define, segment, and project the market ... Application, the report describes major application share of regional market. Application mentioned as follows: Hospital Pharmacy Retail Pharmacy ...

January 2019 78 pages

Filters

Clear all